HAM
AMRX icon

Hedges Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Hedges Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50,000
Closed -$303K – 112
2024
Q1 		$303K Sell
50,000
-34,600
-41% -$195K 0.21% 89
2023
Q4 		$514K Hold
84,600
– – 0.4% 63
2023
Q3 		$357K Hold
84,600
– – 0.31% 76
2023
Q2 		$262K Hold
84,600
– – 0.22% 91
2023
Q1 		$118K Buy
84,600
+34,600
+69% +$68.9K 0.1% 102
2022
Q4 		$99.5K Sell
50,000
-25,000
-33% -$56K 0.09% 105
2022
Q3 		$152K Hold
75,000
– – 0.15% 99
2022
Q2 		$239K Hold
75,000
– – 0.23% 88
2022
Q1 		$313K Hold
75,000
– – 0.24% 92
2021
Q4 		$359K Buy
+75,000
New +$374K 0.28% 87

Other funds holding AMRX

UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return